DTNIX | NYLIX | DTNIX / NYLIX | |
Total Expense Ratio | 0.55 | 0.58 | 95% |
Annual Report Gross Expense Ratio | 0.72 | 0.58 | 124% |
Fund Existence | 11 years | 14 years | - |
Gain YTD | -2.525 | -1.651 | 153% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 1000000 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 271M | 583M | 46% |
Annual Yield % from dividends | 3.94 | 3.55 | 111% |
Returns for 1 year | -0.79 | 0.12 | -636% |
Returns for 3 years | 5.08 | 8.49 | 60% |
Returns for 5 years | 3.88 | 5.91 | 66% |
Returns for 10 years | 14.77 | 11.87 | 124% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
NIOCX | 13.33 | 0.12 | +0.91% |
Neuberger Berman Intl Small Cap C | |||
GQFPX | 11.91 | 0.03 | +0.25% |
GQG Partners Global Quality Value Fd Inv | |||
FSMEX | 58.82 | -0.03 | -0.05% |
Fidelity Select Medical Tech and Devcs | |||
FMFMX | 15.05 | -0.03 | -0.20% |
Fidelity Advisor Series Equity Gr | |||
FIQPX | 51.60 | -0.15 | -0.29% |
Fidelity Advisor Emerging Asia Z |